Dima Shulkin/LinkedIn
Apr 29, 2026, 15:46
Dima Shulkin: Comparing HALP and PIV for Mortality Prediction in ACS
Dima Shulkin, Co-Founder and CTO at RobotDreams GmbH, shared a post on LinkedIn:
“A new multicenter study in acute coronary syndrome puts two simple blood-based scores under the microscope: PIV, a combined immune-inflammation value, and HALP, a score built from hemoglobin, albumin, lymphocytes and platelets.
In 1.134 hospitalized patients, HALP predicted mortality better than PIV, with an AUROC of 0.722 versus 0.619, meaning it separated higher-risk from lower-risk patients more reliably.
The striking part is that this signal came from routine admission labs, not from a complex new test.”
Stay updated with Hemostasis Today.
-
Apr 29, 2026, 15:48Kriti Batni: Happy to Share on Our Chapter Being Published in Medicine Update 2026
-
Apr 29, 2026, 15:44Sonal Sonu: Securing First Prize in Research Oral Presentation at the CME
-
Apr 29, 2026, 15:43Andrew Shaw: Long COVID First Diagnostic Classification with 69% accuracy
-
Apr 29, 2026, 15:41Yazan Abou-Ismail: Contributing Evidence-Based Topic Review on the Evaluation of Easy Bruising
-
Apr 29, 2026, 15:36Mohamed Sherif Salem: Expanding the Role of Tenecteplase in Acute Ischemic Stroke
-
Apr 29, 2026, 15:31WFH Humanitarian Aid Program Reflects on a Result of Years of Consistent Work with AHTA – Yeolyan Hematology and Oncology Center
-
Apr 29, 2026, 15:29Behnood Bikdeli: A Landmark JACC Journals Issue on Pulmonary Embolism
-
Apr 29, 2026, 15:04Heghine Khachatryan: When Bleeding Speaks – Think Beyond Gynecology
-
Apr 29, 2026, 15:01Patrick James Lynch: Speaking About the Risks and Benefits of Rebalancing Agents to Treat Hemophilia